BioNTech SE (BNTX) EPS (Basic) (2018 - 2025)
BioNTech SE (BNTX) posted EPS (Basic) of -$0.72 for Q4 2025, down 289.96% sequentially from $0.38 in Q3 2025, and down 147.33% YoY from $1.52 in Q4 2024.
BioNTech SE (BNTX) EPS (Basic) (2018 - 2025) Analysis & Trends
BioNTech SE has reported EPS (Basic) for 8 years, with the latest figure at -$0.72 in Q4 2025.
- Quarterly EPS (Basic) fell 147.33% year-over-year to -$0.72 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.37 (down 40.75% YoY) and the FY2025 annual result came in at -$5.31, down 79.58% from the prior year.
- EPS (Basic) slipped to -$0.72 in Q4 2025 per BNTX's latest filing, from $0.38 in the prior quarter.
- Over five years, EPS (Basic) peaked at $30.67 in Q3 2021 and troughed at -$3.6 in Q2 2024.
- A 5-year average of $6.98 and a median of $1.42 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2025: EPS (Basic) soared 1359095601993.31% in 2021, then tumbled 147.33% in 2025.
- Over 5 years, EPS (Basic) stood at $0.0 in 2021, then soared by 114873606.68% to $17.05 in 2022, then sank by 77.22% to $3.88 in 2023, then tumbled by 60.76% to $1.52 in 2024, then sank by 147.33% to -$0.72 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.72, $0.38, and -$1.97 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | -0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.73 |
| Sep 30, 2025 | 0.38 |
| Jun 30, 2025 | -1.97 |
| Mar 31, 2025 | -2.08 |
| Dec 31, 2024 | 1.52 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | -3.60 |
| Mar 31, 2024 | -1.57 |
| Dec 31, 2023 | 3.88 |
| Sep 30, 2023 | 1.32 |
| Jun 30, 2023 | -2.84 |
| Mar 31, 2023 | 4.03 |
| Dec 31, 2022 | 17.05 |
| Sep 30, 2022 | 12.82 |
| Jun 30, 2022 | 12.97 |
| Mar 31, 2022 | 29.15 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 30.67 |
| Jun 30, 2021 | 26.90 |
| Mar 31, 2021 | 11.05 |